Ensysce Biosciences, Inc.

ENSC · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 10 employees
210
SEC Filings
$0.4001
Close 2026-09-24
10
Employees

Business Summary

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company developing innovative opioid pain products designed to resist misuse, abuse, and overdose. Its primary platforms include TAAP (Trypsin Activated Abuse Protection) and MPAR (Multi-Pill Abuse Resistant) prodrug technologies. Lead candidates include PF614, a TAAP oxycodone prodrug, and PF614-MPAR, a combination product with nafamostat. PF614-MPAR received FDA Breakthrough Therapy designation in January 2024. The company is headquartered in La Jolla, California.

Latest Stock Quote

ENSC 2026-09-24 $0.4001 O:$0.4258 H:$0.4258 L:$0.3971 Vol:0.3M VWAP:$0.4063
origin leaf: null

Next Earnings

expected 2026-11-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001493152-26-013633EDGAR84K words
2025-03-102024-12-310001493152-25-009703EDGAR83K words
2024-03-152023-12-310001493152-24-009993EDGAR91K words
2023-03-302022-12-310001493152-23-009844EDGAR88K words
2022-03-312021-12-310001493152-22-008438EDGAR—
2021-03-152020-12-310001213900-21-015361EDGAR—
2020-03-102019-12-310001213900-20-005867EDGAR—
2019-03-112018-12-310001615774-19-003912EDGAR—
2018-03-092017-12-310001615774-18-001769EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001493152-26-037817EDGAR25K words
2025-11-142025-09-300001493152-25-023498EDGAR25K words
2025-08-132025-06-300001641172-25-023512EDGAR24K words
2025-05-132025-03-310001641172-25-009955EDGAR22K words
2024-11-122024-09-300001493152-24-044768EDGAR23K words
2024-08-142024-06-300001493152-24-032263EDGAR23K words
2024-05-132024-03-310001493152-24-018718EDGAR22K words
2023-11-092023-09-300001493152-23-040091EDGAR30K words
2023-08-112023-06-300001493152-23-027659EDGAR29K words
2023-05-152023-03-310001493152-23-017430EDGAR27K words
2022-11-142022-09-300001493152-22-032094EDGAR—
2022-08-112022-06-300001493152-22-022103EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-250001493152-26-040080EDGAR1K words
2026-08-240001493152-26-039898EDGAR1K words
2026-08-130001493152-26-037794EDGAR3K words
2026-08-060001493152-26-036268EDGAR2K words
2026-07-150001493152-26-033360EDGAR1K words
2026-04-030001493152-26-015139EDGAR1K words
2026-03-300001493152-26-013622EDGAR3K words
2026-03-300001493152-26-013314EDGAR1K words
2026-03-230001493152-26-012062EDGAR1K words
2026-02-270001493152-26-008343EDGAR1K words

210 total filings indexed. 179 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

prescription-opioid-pain-management abuse-deterrent-opioid-formulations opioid-use-disorder-treatment chronic-pain-treatment acute-pain-treatment 505(b)(2)-fda-regulatory-pathway breakthrough-therapy-designation investigational-new-drug-(ind)-application

Company Identity

CIK0001716947
TickerENSC
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersLa Jolla, California
Websitehttps://www.ensysce.com
Listed2021-07-01

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 5b12cc3b2182804d95bd411443b90f0898b5b9ae96f7c9d017cea18fc006ca69
parent: 40b1b88ad6b19d4fc0f298b681d55c2513ded25c37e31d546f74ba571917ebb6
content hash: 714b9e8e1823c281b392d3434ea0804f92d54a551ad2ba6ffab5fa0d569e8f05
signed: 2026-09-29T12:01:15.115Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ENSC using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ENSC, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ENSC (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.